Joseph Harold Friedman
#153,607
Most Influential Person Across History
Joseph Harold Friedman's AcademicInfluence.com Rankings
Download Badge
Biology
Joseph Harold Friedman's Degrees
- PhD Neuroscience Stanford University
Why Is Joseph Harold Friedman Influential?
(Suggest an Edit or Addition)Joseph Harold Friedman's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. (1993) (1186)
- A contribution of novel CNVs to schizophrenia from a genome-wide study of 41,321 subjects: CNV Analysis Group and the Schizophrenia Working Group of the Psychiatric Genomics Consortium (2016) (1125)
- Effect of deprenyl on the progression of disability in early Parkinson's disease. (1989) (886)
- Fatigue in Parkinson's disease: A review (2007) (322)
- A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. (2014) (294)
- Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease (1997) (290)
- Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis (2010) (238)
- Orienting of visual attention in progressive supranuclear palsy. (1988) (229)
- Neuropsychiatric symptoms in Parkinson's disease (2011) (225)
- Atypical antipsychotics in the treatment of drug‐induced psychosis in Parkinson's disease (2000) (223)
- Spinal Cord Infarction: Report of 8 Cases and Review of the Literature (1989) (221)
- Longitudinal outcome of Parkinson’s disease patients with psychosis (2003) (219)
- Effects of fatigue on physical activity and function in patients with Parkinson’s disease (2003) (215)
- Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial. (2014) (205)
- Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease (2010) (203)
- Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson’s disease (2002) (186)
- Political Correctness. (2017) (180)
- A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal. (1985) (169)
- Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes. (1995) (165)
- Scales to assess psychosis in Parkinson's disease: Critique and recommendations (2008) (158)
- Rotigotine and specific non-motor symptoms of Parkinson's disease: post hoc analysis of RECOVER. (2013) (145)
- Gait in the elderly. (2008) (143)
- Fatigue in levodopa-naïve subjects with Parkinson disease (2008) (140)
- The emergin role of clozapine in the treatment of movement disorders (1997) (136)
- 'It's complicated'. (2014) (131)
- Traumatic brain injury and schizophrenia in members of schizophrenia and bipolar disorder pedigrees. (2001) (125)
- Long‐term outcome of quetiapine use for psychosis among parkinsonian patients (2003) (125)
- Open‐label flexible‐dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease (2006) (123)
- Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. (2010) (123)
- Punding on L‐dopa (1999) (116)
- Aripiprazole for Drug-Induced Psychosis in Parkinson Disease: Preliminary Experience (2004) (115)
- Clozapine in the treatment of psychosis in Parkinson's disease (1989) (114)
- Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease. (1999) (113)
- The placebo response in Parkinson's disease. Parkinson Study Group. (1999) (109)
- Crimes against humanity. (2017) (106)
- Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies. (2002) (106)
- Does fluoxetine exacerbate Parkinson's disease? (1992) (104)
- Double‐blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients (2004) (104)
- Ophthalmologic features of Parkinson's disease. (2004) (101)
- Mood and sleep in Parkinson's disease. (2006) (101)
- Clozapine for the treatment of drug‐induced psychosis in Parkinson's disease: Results of the 12 week open label extension in the PSYCLOPS trial (2001) (101)
- Levodopa improves motor function without impairing cognition in mild non-demented Parkinson's disease patients (1998) (99)
- Respiratory muscle dysfunction in Parkinson's disease. (1988) (97)
- What is a disease? (2017) (96)
- Conventional or atypical antipsychotics and the risk of femur fracture among elderly patients: results of a case-control study. (2007) (94)
- A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease (2017) (92)
- Programming and execution of sequential movements in Parkinson's disease. (1987) (91)
- Parkinson's disease psychosis 2010: a review article. (2010) (90)
- Punding on levodopa (1994) (89)
- The management of the levodopa psychoses. (1991) (88)
- Benztropine versus clozapine for the treatment of tremor in Parkinson's disease (1997) (88)
- Updating the recommendations for treatment of tardive syndromes: A systematic review of new evidence and practical treatment algorithm (2018) (88)
- Quetiapine for the treatment of drug‐induced psychosis in Parkinson's disease (1999) (87)
- CLASSIFICATION AND TREATMENT OF TARDIVE SYNDROMES (2003) (85)
- Sleep and fatigue in Parkinson's disease. (2004) (85)
- Parkinson Disease Psychosis: Update (2013) (84)
- The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease. (2014) (83)
- Prevalence, Clinical Characteristics, and Pharmacologic Treatment of Parkinson's Disease in Residents in Long‐Term Care Facilities (1999) (83)
- Parkinson's disease‐related fatigue: A case definition and recommendations for clinical research (2016) (81)
- Executive and emotional dysfunction in Machado‐Joseph disease (2002) (81)
- Management of the hospitalized patient with Parkinson's disease: current state of the field and need for guidelines. (2011) (80)
- Reduction of freezing of gait in Parkinson's disease by repetitive robot-assisted treadmill training: a pilot study (2010) (80)
- Nonmotor Symptoms in Parkinson's Disease (2017) (79)
- Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. (2010) (78)
- Gamma knife pallidotomy in advanced parkinson's disease (1996) (77)
- Phenomenology of dreams in Parkinson's disease (2007) (76)
- Drug-Induced Psychosis in Parkinson Disease: Phenomenology and Correlations Among Psychosis Rating Instruments (2005) (74)
- REM behavior disorder and excessive daytime somnolence in Machado–Joseph disease (SCA‐3) (2003) (72)
- Rating scales. (2013) (71)
- Respiration and sleep in Parkinson's disease. (1986) (70)
- Hospitalization in Parkinson disease: a survey of National Parkinson Foundation Centers. (2011) (69)
- Mission statements. (2008) (67)
- Physical Activity and Neuropsychiatric Symptoms of Parkinson Disease (2012) (65)
- A comparison of fatigue measures in Parkinson's disease. (2007) (65)
- PRACTICE PARAMETER: ASSESSING PATIENTS IN A NEUROLOGY PRACTICE FOR RISK OF FALLS (AN EVIDENCE-BASED REVIEW): REPORT OF THE QUALITY STANDARDS SUBCOMMITTEE OF THE AMERICAN ACADEMY OF NEUROLOGY (2009) (65)
- Predictors of depressive symptoms among spouse caregivers in Parkinson's disease (2001) (62)
- Tardive dystonia in a psychiatric hospital. (1987) (62)
- Incidence and mortality trends of aspiration pneumonia in Parkinson's disease in the United States, 1979-2010. (2015) (60)
- Fatigue in Parkinson’s disease: report from a mutidisciplinary symposium (2016) (60)
- Treatment of Psychosis in Parkinson’s Disease (2001) (59)
- Donepezil for Huntington's disease (2000) (58)
- Anxiety and Depression in Parkinson’s Disease (2014) (57)
- Falls and the falls efficacy scale in Parkinson’s disease (2010) (57)
- Cognitive and behavioral features discriminate between Alzheimer's and Parkinson's disease. (2002) (56)
- Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease. (2009) (56)
- Monozygotic twins discordant for Huntington disease after 7 years. (2005) (55)
- Myoclonic dystonia (2004) (55)
- Atypical Antipsychotics in Parkinson-Sensitive Populations (2002) (54)
- Substituting clozapine for olanzapine in psychiatrically stable Parkinson's disease patients: results of an open label pilot study. (1998) (54)
- Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease (2010) (53)
- A double-blind comparison of galantamine hydrobromide ER and placebo in Parkinson disease (2008) (51)
- Long‐term outcome of clozapine use for psychosis in parkinsonian patients (2004) (50)
- Gender differences in the frequency and treatment of behavior problems in Parkinson's disease (2000) (50)
- Olfaction in Parkin heterozygotes and compound heterozygotes (2010) (49)
- Testosterone deficiency and apathy in Parkinson’s disease: a pilot study (2004) (48)
- Idiopathic Parkinson's disease in a chronic schizophrenic patient: long-term treatment with clozapine and L-dopa. (1987) (48)
- Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial. (2021) (47)
- The course of tardive dyskinesia and parkinsonism in psychiatric inpatients: 14-year follow-up (2001) (47)
- Clozapine treatment of psychosis in patients with tardive dystonia: Report of three cases (1994) (47)
- Cognitive and motor function in long-duration PARKIN-associated Parkinson disease. (2014) (46)
- Withdrawing amantadine in dyskinetic patients with Parkinson disease: The AMANDYSK trial (2014) (46)
- Preparation of manual movements in hemiparkinsonism. (1989) (44)
- Crack cocaine use due to dopamine agonist therapy in Parkinson disease (2013) (44)
- Recent developments in drug-induced movement disorders: a mixed picture (2019) (43)
- Rapid diagnosis. (2015) (42)
- Sleep symptoms and their clinical correlates in Machado–Joseph disease (2009) (41)
- Limb dystonia in progressive supranuclear palsy (1987) (41)
- Current Use of Clozapine in Parkinson Disease and Related Disorders (2010) (41)
- Orally Disintegrating Selegiline in Parkinson Patients With Dopamine Agonist-Related Adverse Effects (2010) (41)
- Psychogenic disorders: the need to speak plainly. (2010) (41)
- Olfaction and apathy in Parkinson's disease. (2010) (40)
- Dementia with Lewy Bodies and Parkinson Disease Dementia: It is the Same Disease! (2018) (40)
- A survey of Parkinson's disease patients: most bothersome symptoms and coping preferences. (2014) (39)
- Idiopathic hypoparathyroidism with extensive brain calcification and persistent neurologic dysfunction (1987) (38)
- Late onset of distinct neurologic syndromes in galactosemic siblings (1989) (38)
- The Role of Atypical Antipsychotics in the Treatment of Movement Disorders (1999) (37)
- Atypical antipsychotics in the EPS-vulnerable patient (2003) (36)
- The relation between depression and parkin genotype: the CORE-PD study. (2011) (36)
- Non-Motor Aspects of Parkinson's Disease (2006) (36)
- Hypotension due to glossopharyngeal neuralgia. (1986) (36)
- Apathy in Neurodegenerative Diseases (2015) (35)
- A controlled trial of lazabemide (Ro 19-6327) in levodopa-treated Parkinson's disease. Parkinson Study Group. (1994) (35)
- Global aphasia in multiple sclerosis (1983) (35)
- Sleep Disturbances and Parkinson's Disease (2008) (34)
- Risperidone and parkinson's disease (2002) (34)
- Cognitive behavioral therapy for psychogenic movement disorder (2009) (34)
- Attention-Deficit and Disruptive Behavior Disorders (2014) (33)
- Motor asymmetry over time in Parkinson’s disease (2018) (33)
- Botulinum toxin type B for gait freezing in Parkinson's disease. (2004) (30)
- Experience with DaTscan at a tertiary referral center. (2015) (30)
- Parkinsonism in a Nursing Home: Underrecognition (2004) (29)
- 'Drug holidays' in the treatment of Parkinson's disease. A brief review. (1985) (29)
- “Rubral” tremor induced by a neuroleptic drug (1992) (29)
- Chronic pain in Machado-Joseph disease: a frequent and disabling symptom. (2007) (28)
- Yawning as an aura for an L-dopa-induced "on" in Parkinson's disease (1998) (28)
- Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive‐enhancing medications (2018) (28)
- It's all in your head. (2004) (28)
- Atypical antipsychotic use and risk of fracture in persons with Parkinsonism (2009) (28)
- Testosterone not associated with violent dreams or REM sleep behavior disorder in men with Parkinson's (2007) (28)
- Dystonia in Machado-Joseph disease: Clinical profile, therapy and anatomical basis. (2015) (27)
- Fatigue in Parkinson’s disease patients (2009) (27)
- Diabetes mellitus among parkinsonian patients treated chronically with clozapine. (2004) (27)
- Atypical Antipsychotic Drugs in the Treatment of Parkinson’s Disease (2011) (27)
- CACNA1A Mutation in a EA-2 Patient Responsive to Acetazolamide and Valproic Acid (2006) (26)
- Repetitive and impulsive behaviors in treated Parkinson disease (2006) (25)
- Historical perspective on movement disorders. (2004) (25)
- Gender differences in the frequency and treatment of behavior problems in Parkinson's disease. SAGE Study Group. Systematic Assessment and Geriatric drug use via Epidemiology. (2000) (25)
- Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study (2010) (25)
- The association between fatigue and apathy in patients with either Parkinson's disease or multiple sclerosis. (2015) (24)
- Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3 (2020) (23)
- Inflammation and fatigue in early, untreated Parkinson's Disease (2018) (22)
- Machado‐joseph disease/spinocerebellar ataxia 3 responsive to buspirone (1997) (22)
- THE NONMOTOR PROBLEMS OF PARKINSON'S DISEASE (2000) (22)
- Levodopa addiction in idiopathic Parkinson disease (2005) (22)
- Treating psychosis in movement disorder patients: a review (2014) (22)
- Progressive parkinsonism in boxers. (1989) (22)
- Atypical antipsychotics in the elderly with Parkinson disease and the “black box” warning (2006) (21)
- The management of psychosis in movement disorder patients (2007) (21)
- Non‐movement disorder heralds symptoms of Machado‐Joseph disease years before ataxia (2005) (21)
- The contribution of apathy and increased learning trials to risky decision-making in Parkinson's disease. (2014) (21)
- Neuroleptic malignant syndrome. The results of a 6-month prospective study of incidence in a state psychiatric hospital. (1988) (21)
- Fatigue in Parkinson's disease (2011) (21)
- Is altropane SPECT more sensitive to fluoroDOPA PET for detecting early Parkinson's disease? (2001) (20)
- Fatigue and daytime somnolence in Machado Joseph Disease (spinocerebellar ataxia type 3) (2008) (20)
- Suggestive linkage of chromosome 10p to schizophrenia is not due to transmission ratio distortion. (1999) (20)
- Letter to the Editor: Successful Use of Electroconvulsive Therapy for Refractory Anxiety in Parkinson's Disease (2012) (19)
- Melperone is ineffective in treating Parkinson's disease psychosis (2012) (19)
- SPG11‐related parkinsonism: Clinical profile, molecular imaging and l‐dopa response (2018) (19)
- A case of senile chorea (1990) (19)
- Hemi‐parkinsonism due to a midbrain arteriovenous malformation: dopamine transporter imaging (2001) (18)
- Associations between Severity of Motor Function and Nonmotor Symptoms in Parkinson's Disease: A Post Hoc Analysis of the RECOVER Study (2014) (18)
- Pharmacological interventions for psychosis in Parkinson’s disease patients (2018) (18)
- The relationship between obsessive‐compulsive symptoms and PARKIN genotype: The CORE‐PD study (2015) (17)
- Autopsy follow-up of a patient with schizophrenia and presumed idiopathic Parkinson's disease. (2001) (17)
- Apathy in Neurodegenerative Diseases: Recommendations on the Design of Clinical Trials (2015) (17)
- Best medical schools. (2009) (17)
- Parkinson's disease update. (1989) (16)
- Ataxia without telangiectasia (1993) (16)
- Syndrome of diffuse encephalopathy due to nondominant thalamic infarction (1985) (16)
- Analogies (1921) (15)
- Pimavanserin for the treatment of Parkinson's disease psychosis (2013) (15)
- Recognition and treatment of neuropsychiatric disturbances in Parkinson’s disease (2015) (15)
- Permanent cerebellar toxicity of cytosine arabinoside (Ara C) in a young woman (2001) (15)
- Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease (2019) (15)
- Conversion disorder (2010) (15)
- Electroconvulsive Therapy in Parkinson's Disease: A Report on Five Cases. (1992) (15)
- Tardive dystonia due to aripiprazole use in a neuroleptic-naive patient. (2010) (15)
- PLA2G6 mutations and Parkinsonism: Long‐term follow‐up of clinical features and neuropathology (2016) (15)
- Misperceptions and Parkinson's disease (2017) (15)
- Weight problems and psychological factors. (1959) (15)
- Re: Atypical Antipsychotics Mechanisms of Action (2003) (14)
- Cognitive Effects of Rasagiline in Mild-to-Moderate Stage Parkinson's Disease Without Dementia. (2017) (14)
- Ice cream preference in Parkinson's disease. (2010) (14)
- A Retrospective Study of Pimavanserin Use in a Movement Disorders Clinic (2017) (14)
- Unrecognized parkinsonism in acute care medical patients receiving neurological consultations. (2003) (14)
- Viewpoint: challenges in our understanding of neuroleptic induced parkinsonism. (2014) (14)
- Tardive Dyskinesia‐like Syndrome Due to Drugs that do not Block Dopamine Receptors: Rare or Non‐existent: Literature Review (2018) (13)
- Self perceived weakness in Parkinson's disease. (2012) (13)
- A family with a tau P301L mutation presenting with parkinsonism. (2002) (13)
- Stroke induced by gamma knife pallidotomy: autopsy result. (2002) (13)
- Rhinorrhea is increased in Parkinson's disease (2008) (12)
- RHINORRHEA AND OLFACTION IN PARKINSON DISEASE (2008) (12)
- Drug-induced parkinsonism in the elderly (2007) (12)
- Feasibility of use of probabilistic reversal learning and serial reaction time tasks in clinical trials of Parkinson's disease. (2015) (12)
- An investigation of the coexistence of abnormal involuntary movements, parkinsonism, and akathisia in chronic psychiatric inpatients. (1987) (11)
- Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease (2019) (11)
- Enteric Pathologic Manifestations of Alpha-Synucleinopathies (2017) (11)
- Systematic review of caudal epidural injections in the management of chronic back pain. (2013) (11)
- Gold standards. (2009) (10)
- Progressive parkinsonism associated with Rosenthal fibers (1992) (10)
- Neuropsychiatric Symptoms in an Inpatient Parkinson's Disease Sample (2014) (10)
- Hiccups and vomiting as initial manifestations of multiple sclerosis. (1987) (10)
- Quetiapine for Parkinson's Disease psychosis: Evidence‐based medicine versus expert belief: A case study (2018) (10)
- Is Urinary Incontinence Different in Women with Parkinson’s Disease? (1999) (9)
- Internal tremor in Parkinson's disease, multiple sclerosis, and essential tremor. (2015) (9)
- Movement disorders induced by psychiatric drugs that do not block dopamine receptors. (2020) (9)
- Managing idiopathic Parkinson's disease in patients with schizophrenic disorders. (2011) (8)
- Tardive Dyskinesia-like Syndrome Due to Drugs that do not Block Dopamine Receptors: Rare or Non-existent: Literature Review (2018) (8)
- No brainer. (2000) (8)
- Ageism in Health Care? (2015) (8)
- Cervical stenosis and dystonic cerebral palsy (1999) (8)
- Clinical Vignettes in Parkinson's Disease: A Collection of Unusual Medication-Induced Hallucinations, Delusions, and Compulsive Behaviours (2011) (8)
- Pimavanserin for Psychotic Symptoms in People With Parkinsonism: A Second Chart Review (2018) (8)
- More on repetitive behaviors in Parkinson's disease (2005) (8)
- Neurodegenerative disorders mimicking progressive supranuclear palsy: a report of three cases (2005) (8)
- Young‐onset Parkinson's disease: A clinical pathologic description of two siblings (2000) (8)
- Valbenazine-induced parkinsonism. (2019) (7)
- Progressive myalgias and polyarthralgias in a patient with myoadenylate deaminase deficiency. (1985) (7)
- Glad about SAD (PD) (2012) (7)
- Walking‐induced parkinsonism due to presumed idiopathic normal pressure hydrocephalus (1996) (7)
- Akathisia with clozapine (1993) (7)
- An open trial of controlled release carbidopa/L-dopa (sinemet CR) for the treatment of mild-to-moderate Parkinson's disease. (1989) (7)
- Dementia, ataxia and parkinsonism associated with the antiphospholipid syndrome. (2011) (6)
- Reducing risk factors. (2011) (6)
- Rapid resolution of organic mental syndrome in sickle cell anemia in response to exchange transfusion (1981) (6)
- Akathisia: the syndrome of motor restlessness. (1987) (6)
- Psychiatry for neurologists (2006) (6)
- Multiple re-challenges for clozapine neutropenia in Parkinson's disease. (2016) (6)
- Tardive syndromes in the elderly. (2006) (6)
- Spinal surgery for severe scoliosis in Parkinson's disease. (2000) (6)
- Enhanced fatigue during motor performance in patients with PD. (1999) (6)
- Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease Patient. (2017) (6)
- Behavioral dysfunction in Parkinson's disease. (1998) (6)
- Atypical antipsychotics have very different adverse effect profiles and should not be lumped together. (2006) (5)
- Editorial on: Pagonabarraga J, Martinez‐Hora S, Fernandez de Bobadilla R et al. Minor hallucinations occur in drug‐naïve Parkinson's disease patients even from the premotor phase. Movement Disorders 2015; Available from: DOI: 10.1002/mds.26432 (2016) (5)
- Hemifacial gustatory sweating due to Pancoast's tumor. (1987) (5)
- Long-term outcomes with pimavanserin for psychosis in clinical practice (2022) (5)
- Psychosis in Parkinson’s disease: unexplained observations in a seemingly simple model (2016) (5)
- Involuntary humming in autopsy-proven Parkinson's disease. (1993) (5)
- A case of progressive hemichorea responsive to high-dose reserpine. (1986) (5)
- A-31The Effects of Rasagiline on Cognition in Mild to Moderate Stage Parkinson's Disease, A Double-Blind Placebo Controlled Study (2014) (5)
- Rating instruments. (2008) (5)
- Symptoms of neuroleptic malignant syndrome. (1987) (5)
- Surgical treatment for Parkinson’s disease (2012) (5)
- Advances in neurology, volume 49 (facial dyskinesias). Joseph Jankovic, Edwardo Tolosca, (eds), Raven press, New York, $102.00. 1988 (1989) (5)
- Efficacy and tolerability of NUPLAZID™ (pimavanserin) in PD Psychosis: Analysis of an integrated Phase 3 placebo-controlled dataset (2016) (5)
- Ophthalmologic features of Parkinson's disease. Authors' reply (2004) (4)
- Expert opinions. (2018) (4)
- Is fatigue in early Parkinson’s disease a minor inconvenience or major distress? The answer is ‘yes!’ (2012) (4)
- Rostral basilar reversible ischemic neurologic deficit in an HIV-infected patient with cryptococcal meningitis. (1990) (4)
- Corrigendum: Fatigue in Parkinson’s disease: report from a multidisciplinary symposium (2017) (4)
- Shunting for normal pressure hydrocephalus in patients with neurodegenerative disorders (2013) (4)
- New-Onset Diabetes Mellitus among Parkinsonian Patients Treated with Long-term Quetiapine (2008) (4)
- Medical Tourism. (2016) (4)
- Perioperative management of Parkinson’s disease (2017) (4)
- Should risperidone be used in Parkinson's disease? (1998) (4)
- The placebo effect (2008) (4)
- Intravenous levodopa in hallucinating PD patients. (1999) (4)
- Thalamic infarct and diffuse encephalopathy (1986) (4)
- Mood, Emotion, and Thought (2007) (4)
- Urine levels of the polyglutamine ataxin-3 protein are elevated in patients with spinocerebellar ataxia type 3 (2021) (4)
- Treatment of Parkinson’s Disease Psychosis (2019) (4)
- Acute Parkinsonism (2017) (4)
- Catatonia responsive to lorazepam: A case report (1999) (3)
- The Glabellar reflex is a poor measure of Parkinson motor severity (2013) (3)
- The physical exam. (2014) (3)
- Clozapine and the mandatory monitoring system. (1991) (3)
- Effects of Vestibular Rehabilitation on Fatigue and Activities of Daily Living in People with Parkinson's Disease: A Pilot Randomized Controlled Trial Study (2020) (3)
- Tardive Syndromes. (2019) (3)
- Idiopathic normal pressure hydrocephalus: a revisionist interpretation. (1995) (3)
- Choosing a treatment. (2010) (3)
- Trends and outcomes associated with gastrostomy tube placement in common neurodegenerative disorders (2020) (3)
- Vitamin B12 (cobalamin) and Parkinson’s disease (2012) (3)
- Jaw clonus frequency does not support hypothesis of peripheral mechanism of self-re-excitation (2015) (3)
- Shortness of breath in Parkinson's disease. (2011) (3)
- Dextromethorphan-induced neurologic illness in a patient with negative toxicology findings (2006) (3)
- Alternating unilateral jaw spasm due to metoclopramide. (1986) (3)
- Shared Decision Making or Paternalism? (2016) (2)
- Recommendations on the drug treatment of psychosis in Parkinson's disease. (2010) (2)
- FUNCTIONAL ABILITY AND FUNCTIONAL CAPACITY IN PATIENTS WITH PARKINSON??S DISEASE (2001) (2)
- Author Correction: Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease (2020) (2)
- Medical marijuana in Huntington's disease: report of two cases. (2012) (2)
- Dreams in neurological diseases. (2006) (2)
- Thoughts on fatigue in Parkinson's disease (and other disorders) (2017) (2)
- Treatment of Fatigue in Parkinson’s Disease (2019) (2)
- Antidepressants and movement disorders (2015) (2)
- Number needed to treat (NNT); number needed to harm (NNH). (2012) (2)
- Motor side effects of atypical antipsychotic drugs (2009) (2)
- Etiology and overview (2012) (2)
- Neuroleptic Malignant Syndrome (1987) (2)
- Medication-Induced Movement Disorders (2015) (2)
- Reply from the Authors (1990) (2)
- Vital signs stable. (1999) (2)
- Non-Motor Symptoms and Associated Factors in Parkinson's Disease Patients in Addis Ababa, Ethiopia: A Multicenter Cross-Sectional Study (2021) (2)
- Azorean (Machado-Joseph) disease. (1988) (2)
- 18F-Dopa vs dopamine transporter ligands in positron emission tomographic and single-photon emission computed tomographic scans for Parkinson disease. (2002) (2)
- Book Review Guide to Clinical Neurology Edited by J.P. Mohr and J.C. Gautier. 1030 pp. New York, Churchill Livingstone, 1995. $85. 0-443-08927-2 (1996) (1)
- Comments and Reply on Ikeguchi and Kuroda: Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs (2005) (1)
- Racial and geographic disparities with gastrostomy tube placement in dementia and parkinsonian disorders. (2021) (1)
- Chief complaint. (2011) (1)
- My black bag. (2006) (1)
- Active-controlled versus placebo-controlled trials. (1999) (1)
- Clozapine Use in a Movement Disorder Clinic (2022) (1)
- Brain treatments and creativity. (2014) (1)
- When is a somatic disorder psychiatric? (2008) (1)
- Paroxysmal dyspnea in Parkinson's disease: Respiratory dyskinesias and autonomic hyperventilation are not the same. (2021) (1)
- White Coats. (2017) (1)
- Fast Facts: Psychosis in Parkinson's Disease (2019) (1)
- Early- vs late-start levodopa relieved symptoms but did not affect disease progression in Parkinson disease (2019) (1)
- Absolute Agranulocytosis After 9 Weeks of Clozapine 25 mg Daily. (2022) (1)
- The Naranjo Scale and Tardive Syndromes, a Historical Perspective. (2019) (1)
- Neuropsychiatric disorders: What do neurologists think about conversion disorder? (2011) (1)
- On reviewing manuscripts. (2003) (1)
- Prison ethics. (2011) (1)
- Normal pressure hydrocephalus. (2004) (1)
- Can fall of blood pressure prevent falls in Parkinson disease? (2014) (1)
- Current evidence-based guidelines for the management of Parkinson’s disease (2012) (1)
- Visual hallucinations in photographs in Parkinson's disease (2013) (1)
- Thank God for rich women with mustaches. (2001) (1)
- Gait disorders in the elderly. (2012) (1)
- Re: Clinical feature profile of spinocerebellar ataxia type 1–8 predicts genetically defined subtypes (2007) (1)
- Attention Deficit Hyperactivity Disorders: Animal Models (2014) (1)
- M-E-053 EFFECTS OF TRANSDERMAL ROTIGOTINE ON SLEEP AND NOCTURNAL SYMPTOMS OVER A 1-YEAR PERIOD IN PARKINSON'S DISEASE: AN OPEN-LABEL EXTENSION OF THE RECOVER STUDY (2011) (1)
- Alpha-synuclein pathology in colonic biopsy of a suspected multiple system atrophy patient - a case report (P1.177) (2015) (1)
- The evaluation of the swallow tail sign in patients with parkinsonism and gait disorders (2021) (1)
- Advances in Parkinson's Disease Management (2012) (1)
- Dystonic Gait Developing After Elective, Unremarkable Hip Surgery. (2016) (1)
- Too much of a good thing. (2011) (1)
- Recognising hemihypomimia as a mimic of ‘facial weakness’ (2020) (1)
- Clozapine treatment of psychosis in patients with Parkinson's disease. (1994) (1)
- Psychiatric Aspects of Parkinson’s Disease (2006) (1)
- Anti-Parkinson Drugs (2014) (1)
- Randomized, double-blind, placebo-controlled trials: the gold standard? (2004) (1)
- Chemical imbalance or moral weakness? Personal responsibility in a time of brain science. (2006) (1)
- Comment on: Atypical antipsychotics mechanisms of action. Author's reply (2003) (1)
- Alien abductions as a risk factor for Parkinson's disease [April Fool]. (2003) (1)
- Corrigenda: Minor hallucinations occur in drug‐naive Parkinson's disease patients, even from the premotor phase (2016) (1)
- Really dead. (2002) (1)
- Editorial and introduction: Behavioral aspects of Parkinson's disease (2017) (1)
- Book ReviewMovement Disorders 2 (1987) (1)
- Psychiatry/Neurology Pretest Self Assessment and Review (1981) (1)
- Clozapine Is Severely Underused in Parkinson's Disease Patients (2022) (1)
- A novel promising therapeutic approach for patients with ataxic disorders? (2018) (1)
- IRBs and the private office. (2007) (1)
- Evaluating Oculomotor Tests before and after Vestibular Rehabilitation in Patients with Parkinson's Disease: A Pilot Pre-Post Study (2022) (1)
- Reply: Atypical Antipsychotics Mechanisms of Action (2003) (1)
- Specialists and the current medical "system". (2000) (0)
- Driving and the physician: a (more) modest proposal. (1999) (0)
- "No autopsy--he's suffered enough.". (2002) (0)
- Second opinions. (2000) (0)
- A Shot to the Gut. (2019) (0)
- How can you be two places at once when you're not anywhere at all? (2012) (0)
- Who's the criminal? (2000) (0)
- The admiral and the General. (2010) (0)
- On Time. (2015) (0)
- MEDICAL HISTORY (2002) (0)
- Non-Paroxysmal Progressive Ataxia in an Adult Due to a Novel Mutation of the CACNA 1 A Gene (2017) (0)
- Doctors falling down on the job. (2017) (0)
- "Medical marijuana" use in a movement disorders clinic in Rhode Island. (2014) (0)
- Letter on Proposals for Gait Research (2022) (0)
- Establishing a legacy: the Aronson Chair for Neurodegenerative Disorders. (2013) (0)
- Medical etiquette: pro and con. (1999) (0)
- Fatigue: A Common Comorbidity in Parkinson’s Disease (2013) (0)
- New anti-parkinsonian drugs. (1998) (0)
- Doctor's revenge. (2006) (0)
- Localizing the wandering uterus. (2010) (0)
- Supplements (1992) (0)
- Reimbursement for experience-based medicine. (2009) (0)
- The Journal of Goldberg Research (April Fool). (2007) (0)
- Imaging in medication-induced parkinsonism (2015) (0)
- Apathy in Parkinson disease (2020) (0)
- Inpatient Mortality in Parkinson’s Disease (2023) (0)
- Gamma Knife I ’ allidotomv / in Advanced Parkinson ’ s Disease (2004) (0)
- Better than medicine. (2001) (0)
- Voting Aliens, Donald Trump and Me. (2017) (0)
- Sporadic Parkinsonism-Dementia Complex of Rhode Island with Unusually Abundant Glial TDP-43 Immunoreactivity (2017) (0)
- Maprotiline-induced ataxia. (1986) (0)
- Self-perception of tremor and dyskinesia (P5.283) (2015) (0)
- Announcing a new continuing medical education course: “Bridging Neurology and Psychiatry: Movement Disorders”. (2013) (0)
- Rat doctors. (2008) (0)
- Controversies in the treatment of Parkinson's disease. (1985) (0)
- Combined dopaminergic and nondopaminergic therapies (2012) (0)
- Past exposure to neuroleptics is associated with the risk of developing Parkinson's disease (2012) (0)
- Apathy in Parkinson's disease: Why we should care. (2020) (0)
- The Misperceived Curmudgeon. (2016) (0)
- James Parkinson did NOT describe respiratory changes in The Shaking Palsy. (2023) (0)
- Acute Onset Parkinsonism in a Middle-Aged Alcoholic: A “Great Case” (2012) (0)
- Infected teeth and blind eyes. (2006) (0)
- Trojan horse advertising. (1999) (0)
- Being solicitous or getting even? (2002) (0)
- Parkinson's disease update. (1989) (0)
- Tardive Dyskinesia due to Aripiprazole. (2021) (0)
- Eponyms: What's in a Name? (2023) (0)
- To the Editor (1990) (0)
- Neurological novels. (2013) (0)
- Are atypical antipsychotics associated with a reduced risk of developing parkinsonism? (2006) (0)
- Journal Watch: Our panel of experts highlight the most important research articles across the spectrum of topics relevant to the field ofClinical Practice (2012) (0)
- Rotigotine Transdermal System Improves Pain in Patients with Parkinson's Disease: A Post-Hoc Analysis of Patients Reporting Pain in the RECOVER Study (P06.085) (2012) (0)
- Butler Hospital announces the Aronson Chair for Neurodegenerative Disorders. (2014) (0)
- CORRECTION (2008) (0)
- Introduction to geriatric neurology issue. (2008) (0)
- Winning the battle but losing the war: many silver linings are in clouds. (2005) (0)
- Gait abnormalities are too hard to evaluate, so why bother? (2005) (0)
- Sleep disturbances in Parkinson’s disease: beyond a regional perspective. Time to do something about it (2020) (0)
- Demented politicians. (2002) (0)
- "The evil among us" or "the buck stops there". (2003) (0)
- Estimating the Cumulative Risk of PD in Carriers of Parkin Mutations: The CORE-PD Study (PD4.007) (2012) (0)
- Knee lichenification in Parkinson's disease: "Parkinson knees". (2009) (0)
- Medical conferences. (2010) (0)
- Hanging the crepe. (2010) (0)
- A new paradigm for clinical studies? (2011) (0)
- Biased articles. (2009) (0)
- Clinically Determined Asterixis Is Markedly Increased in Patients Taking Clozapine (2023) (0)
- The Not-So-Near Death of Autopsies in the U.S. (2016) (0)
- Evidence-based medicine & medical myths. (2000) (0)
- Neurology In Primary Care (1998) (0)
- My African experiences. (2013) (0)
- A Good Partner Makes the Difference What ' s in a Name ? ? ? (2005) (0)
- Ignorance is bliss? An ethical question. (2004) (0)
- Astasia-abasia as an incidental finding. (2006) (0)
- Letters to the editor (0)
- Klinefelter's Syndrome with Tremors, Ataxia and Parkinsonism. (2023) (0)
- Reporting enrollment in clinical trials. (2002) (0)
- Reply (2000) (0)
- Book ReviewPrinciples of Neurology (1990) (0)
- Movement disorders: resources in Rhode Island. (1993) (0)
- Biomarkers of Parkinson’s disease (2012) (0)
- 'How not to do things' - FDA approval of new Alzheimer's drug triggers controversy. (2021) (0)
- My ties to big pharma. (2008) (0)
- Development of low weight forgings (1948) (0)
- Evolving medicine. (2001) (0)
- Short report Preparation of manual movements in hemiparkinsonism (2004) (0)
- Negative hallucinations [April Fool's]. (2010) (0)
- Getting Wiser, or Just More Crotchety? (2021) (0)
- The Good Neighbor Alliance (2008) (0)
- Peer review: phony data, shoddy work or revolutionary results? "Truth will out". (2000) (0)
- The Effect of Parkin Mutation Status on Cognitive Functioning in EOPD Patients with Long Disease Duration: The CORE-PD Study (PD7.008) (2012) (0)
- Cognitive Sinks & the Bermuda Triangle of fMRI Cognitive Studies. (2021) (0)
- Short report Tardive dystonia in a psychiatric hospital (0)
- The Blue Cross & Blue Shield of RI and Brown University Collaboration (0)
- Breaking bad news. (2013) (0)
- Recent research advances in Parkinson's disease: Part I. (1986) (0)
- The why of neurological reflexes. (2018) (0)
- Tardive dystonia inapsychiatric hospital (1987) (0)
- The woman who could spell backwards. (2017) (0)
- Comment on: Tardive dyskinesia model in the common marmoset (2003) (0)
- Introduction to the aging brain, Part 1. (2012) (0)
- Retirement: for better or worse? (2014) (0)
- Atypical antipsychotics and movement disorders (2015) (0)
- A TV moment. (2003) (0)
- Increased interleukin 1RA and VCAM 1 in Parkinson patients with fatigue (2017) (0)
- Parkinsonian side effects of atypical antipsychotics in the elderly (2005) (0)
- On being grandfathered. (2005) (0)
- Failing marks in optimism. (2012) (0)
- Treating Depression in Parkinson Disease (2009) (0)
- Prison clinical trials. (2000) (0)
- Subjective Memory Impairment and Subjective Cognitive Improvement: Role for D-C2H5OH (Deuterated Ethyl Alcohol)? Results of a Double-Blind, Crossover Trial. (2020) (0)
- Medical errors. (2000) (0)
- Journal Watch: Our panel of experts highlight the most important research articles across the spectrum of topics relevant to Clinical Practice (2012) (0)
- Managing psychosis in Parkinson’s disease (2011) (0)
- Pramipexole for Depression in Parkinson Disease (2010) (0)
- Prior authorizations and denials. (2013) (0)
- What is an animal model ? (2005) (0)
- Sharing bad news. (2006) (0)
- Chapter 118 – Mental Changes in Parkinson's Disease (2003) (0)
- Chapter 85 – Vascular Disease of the Spinal Cord (2003) (0)
- Primary movement disorders. (1990) (0)
- Bariatric surgery in Parkinson's disease patients. (2016) (0)
- Front & Back Matter (2020) (0)
- Knee Lichenification In Parkinson's Disease: (2009) (0)
- Evaluation of Phosphodiesterase 10A (PDE10A) Using MNI-659 PET Imaging in Huntington's Disease (P07.212) (2013) (0)
- Perspectives on the Art of Scientific and Medical Writing. (2023) (0)
- Brain Treatments and Creativity. (2015) (0)
- Research proposal to my readers. (2011) (0)
- Hoffmann's Sign with Clonus. (2023) (0)
- Reflections from the editor-in-chief on 20-year tenure. (2018) (0)
- Curing lawyers [April fool's]. (2005) (0)
- Talkative patients. (2017) (0)
- Acronyms: what's in a name? (2009) (0)
- Reply from the authors (0)
- Physician overextenders. (2019) (0)
- Ethical guidelines and guidelines on ethics are not the same. (2007) (0)
- A great case! (2011) (0)
- Response to Point of View on the Question of Bias. (2019) (0)
- Book targets IRB delays in medical research; proposes a more humane paradigm. (2023) (0)
- Culture gaps. (2006) (0)
- When the doctor is crazier than the patient. (2017) (0)
- An up-front guide to getting promoted: slow and steady. (2014) (0)
- Best doctors. (2000) (0)
- UNDER THE JOINT EDITORIAL SPONSORSHIP OF (2006) (0)
- Magaziner on healthcare reform: lower administrative costs, empower physicians, providers. (2014) (0)
- PHYSICAL ACTIVITY, FUNCTION AND FATIGUE IN PARKINSON??S DISEASE. (2003) (0)
- Author Correction: Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease (2020) (0)
- No stone unturned? (2016) (0)
- Cowboy medicine or good clinical judgment? Testing minimalism. (2010) (0)
- Restless legs syndrome (2015) (0)
- Let sleeping dogs lie. (2014) (0)
- Migraine with unilateral mydriasis. (2016) (0)
- CHAPTER M1 – Drug-Induced Movement Disorders (2005) (0)
- Electronic medical records. (2008) (0)
- Repetitive Behavior (2021) (0)
- Altruism and my nine gallons of blood. (2013) (0)
- Ethics, money & negative studies. (2001) (0)
- Medication trials in an imperfect world: gout and Parkinson's disease. (2009) (0)
- Sleep deprivation and medicine. (2004) (0)
- Treatment-induced mental changes in Parkinson's disease. (2007) (0)
- Use of atypical antipsychotics in neurodegenerative diseases (2006) (0)
- 'Non-physiological' Disorders. (2022) (0)
- "I don't do maintenance". (2012) (0)
- The way things were, or, in the days of the "giants". (2009) (0)
- Medical Passports. (2016) (0)
- The Ecology of Neonatology In Rhode Island : Improving Health Care For Newborns (2010) (0)
- Thoughts on malpractice. (2013) (0)
- Putting on shoes--acts of humility. (2001) (0)
- Editorial to "Increases in institutionalization, healthcare resource utilization, and mortality risk associated with Parkinson disease psychosis: retrospective cohort study" by Friedman et al. (2019) (0)
- Parochialism and biased reviews. (2011) (0)
- April fool's commentary: in praise of placebos. (2006) (0)
- Reporting enrollment in clinical trials. Authors' reply (2002) (0)
- We can't afford to see patients. (2003) (0)
- American Academy of Neurology Practice Parameters: Parkinson Disease Diagnosis and Treatment (2006) (0)
- Ten Percent Brain Function: Fact or Fantasy? (2015) (0)
- Legal overprotection. (2004) (0)
- Checklists: You documented it, but did you do it? (2016) (0)
- Interview: Reflections on three decades of clinical practice and clinical research (2014) (0)
- COMMENTARIES 360 Astasia-Abasia as an Incidental Finding (2006) (0)
- Movement disorders: Neurologic principles and practice. By Ray Watts, MD, and William C. Koller, MD. Ontario, Canada: McGraw‐Hill Ryerson Ltd, 1997, 832 pp., 400 illustrations. Price: $181.25 Canadian. ISBN 0‐07‐035203‐8 (1998) (0)
- YAWNING IN PARKINSON'S DISEASE. AUTHORS' REPLY (1999) (0)
- Management of cognitive and behavioral aspects of Parkinson's disease (2013) (0)
- A good result isn't always a good result. (2007) (0)
- National Parkinson Foundation Hospitalization Survey (2014) (0)
- Parkinson disease. (1987) (0)
- Bloodletting in the 21st Century? (2016) (0)
- Institutional Review Board (IRB) Overreach. (2022) (0)
- Atypical Parkinsonian syndromes with very poor striatal uptake on 123I-ioflupane SPECT imaging. (2015) (0)
- Joe's prior auth service. (2013) (0)
- Needless tests. (2002) (0)
- Three A's or four; or, what do patients want in a doctor? (2010) (0)
- Missed opportunities, missing opportunities and clinical creativity. (2005) (0)
- Upper and (old) lower facial (VII) nerve palsies on opposite sides. (2009) (0)
- Personalized Medicine: Is it a concept only for the super-rich? (2015) (0)
- Centennial Thoughts. (2017) (0)
- Apps replies (1986) (0)
- Dress codes for doctors. (2007) (0)
- Why don't doctors return phone calls? (2021) (0)
- Thanks for the bad news. (2006) (0)
- Looking good, feeling bad, the Marilyn Monroe syndrome. (2001) (0)
- Brain waves and the era of cosmetic neurology. (2011) (0)
- Clinical and Genetic Characteristics of Participants with Juvenile PD: The CORE-PD Study (IN10-2.001) (2012) (0)
- Acute Parkinsonism 9 9 (2017) (0)
- MCI in Parkinson's disease. (2018) (0)
- Management of psychotic symptoms in Parkinson’s disease (2012) (0)
- Voter restrictions in Florida (and elsewhere in the United States). (2012) (0)
- Ebola vaccine and corporate responsibility. (2015) (0)
- Psychosis in Parkinson's Disease (2011) (0)
- Medical Notes (1896) (0)
- Vitamin D deficiency and falls (2011) (0)
- Aiming low: advice to residents considering a research project. (2014) (0)
- Commentary on "The Neuropsychiatry of Parkinson's Disease: A Perfect Storm". (2019) (0)
- Secondary torticollis (1992) (0)
- Yawning, or not having enough to do. (2012) (0)
- Doctors vs. doctors. (2004) (0)
- Treating Agitation in Alzheimer Disease (2007) (0)
- Corrigenda: Eldad Melamed 1942–2015: Ave atque–A memorial (2016) (0)
- On choosing one's patients. (2003) (0)
- Recent research advances in Parkinson's disease: Part II. Studies in lower animals indicate a future for brain implants. (1986) (0)
- Neurology requirements at Brown. (2009) (0)
- Task Specific Tremors. (2015) (0)
- Thinking too much is bad for some brains. (2018) (0)
- Programming andexecution ofsequential movements inParkinson's disease (1987) (0)
- Feudalism or futilism: another modest proposal. (2007) (0)
- Talking About Patients in Front of Them. (2015) (0)
- Graybeards, or grayheads. (2007) (0)
- Where quality is job one? (2003) (0)
- How much is it worth? (2012) (0)
- Where Are the Words To Heal ? (2003) (0)
- NPH on TV. (2005) (0)
- Muscarinic Cholinergic Receptor Agonists and Antagonists (2015) (0)
- Brain cramps. (2002) (0)
- Acute Onset of Akinetic Mutism With Rigidity in an Elderly Psychiatric Patient: A Reminder on Catatonia (2012) (0)
- EBM: evidence-based medicine or experience-based medicine? (2011) (0)
- Anticholinergics in dementia and other confounding problems. (2006) (0)
- Nondystonic torticollis (1993) (0)
- Needless tests. (2002) (0)
- RHINORRHEA AND OLFACTION IN PARKINSON DISEASE. Authors' reply (2008) (0)
- Feeling comfortable with not knowing. (2003) (0)
- Non-motor movement disorders: internal tremor. (2009) (0)
- Cell and gene transplantation for Parkinson’s disease: view from the clinic (2012) (0)
- Anticholinergics in dementia and other confounding problems. Author's reply (2006) (0)
- First do no harm--unless.... (2003) (0)
- Brain warfare: primates to humans? (2014) (0)
- Evidence-based Medicine. (2018) (0)
- Quetiapineof its Clinical Potential in the Management of Psychotic Symptoms in Parkinson's Disease (2000) (0)
- Every silver lining has a cloud. (2005) (0)
- Parkinson, Shaking Palsy MS#1817-010038. reviewer comments [April fools]. (2012) (0)
- My Newest Favorite Hallucination. (2021) (0)
- Recognizing dementia with Lewy bodies in older people (2010) (0)
- Making the Connection Between Brain and Behavior: Coping with Parkinson's Disease (2007) (0)
- Neuroleptic Malignant Syndrome-Reply (1986) (0)
- What to do when bad news isn't understood? (2018) (0)
- Jaundiced eye. (2014) (0)
- Drug therapies for neuropsychiatric and autonomic disturbances in patients with PD (2012) (0)
- Simplicity isn't always a virtue. (2014) (0)
- Small research. (2014) (0)
- Reply (1999) (0)
- Doctor seer. (2005) (0)
- Response to Letter to the Editor (2019) (0)
- The Four Humors (Updated for Neurologists). (2023) (0)
- Continuing medical education (CME): goals and objectives. (2010) (0)
- Presence Hallucinations" in PD Patients. (2020) (0)
- Superaging, the new phrenology, and the gluten-free diet for the brain. (2017) (0)
- Further Thoughts on Antipsychotics in Dementia with Lewy Bodies (2017) (0)
- Standard of Care. (2016) (0)
- An April Fool's Day commentary. What a difference a scale makes! (2002) (0)
- Memory feats. (2014) (0)
- Some thoughts on ethical guidelines for the neurologically-impaired elderly. (2008) (0)
- Psychogenic disorders: the consultants' responsibility, or "rule out" doctors. (2004) (0)
- Common sense. (2007) (0)
- Cognitive behavioral therapy for psychogenic movement disorder (0)
- CATS: a new answer to an old problem. (2008) (0)
- Personalized Medicine in the Resource-poor World. (2016) (0)
- "... But I can still sue you, can't I"? (2007) (0)
- Old Age , Stricken in Years (2005) (0)
- Anger in Patients with Parkinson Disease (2008) (0)
- The academic--corporate interface in medicine. (2000) (0)
- Do quality of life measures measure anything we want to measure? (2008) (0)
- Neuroprotective trials: no longer a cautious optimism. (2008) (0)
- Laughing at patients. (2013) (0)
- Getting older. (2011) (0)
- Why people in RI won't drive far: a scientific explanation. (2009) (0)
- 'Goodbye, and thanks…'. (2018) (0)
- Disorders without explanation. (2014) (0)
- End-of-life discussions. (2015) (0)
- Zambian dilemma, American solution. (2004) (0)
- Publish (if you can). (2014) (0)
- Warning on treating depression. (2010) (0)
- What kind of doctor am I? (2012) (0)
- First annual April (fool's) commentary. Cognitive sinks: the black holes of neuropsychology: a brief overview. (2000) (0)
- What does it mean for a treatment to 'work?'. (2013) (0)
- Neurological stigma. (2013) (0)
- Iatrogenesis imperfecta. (2002) (0)
- Response to Letter to the Editor (2010) (0)
- The surgeon general: why not have one? (2005) (0)
- Self-perception and insight. (2014) (0)
- Break point. (2016) (0)
- At 10 years, 55% of patients with Parkinson disease died; 23% had a good outcome (2013) (0)
- Quackery in the incurable. (2001) (0)
- Into the Ether. (2016) (0)
- Political correctness is unethical. (2009) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Joseph Harold Friedman?
Joseph Harold Friedman is affiliated with the following schools:
